These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9018230)

  • 1. Cancer prognostics: past, present and p27.
    Steeg PS; Abrams JS
    Nat Med; 1997 Feb; 3(2):152-4. PubMed ID: 9018230
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical relevance of expression of the CIP/KIP cell-cycle inhibitors p21 and p27 in laryngeal cancer.
    Pruneri G; Pignataro L; Carboni N; Buffa R; Di Finizio D; Cesana BM; Neri A
    J Clin Oncol; 1999 Oct; 17(10):3150-9. PubMed ID: 10506612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [P27Kip1 is certainly a suppressor gene but with a dose effect].
    Jeanteur P
    Bull Cancer; 1998 Dec; 85(12):990. PubMed ID: 9988555
    [No Abstract]   [Full Text] [Related]  

  • 4. Multiple functions of p27(Kip1) and its alterations in tumor cells: a review.
    Sgambato A; Cittadini A; Faraglia B; Weinstein IB
    J Cell Physiol; 2000 Apr; 183(1):18-27. PubMed ID: 10699962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The concurrent expression of p27(kip1) and cyclin D1 in epithelial ovarian tumors.
    Sui L; Tokuda M; Ohno M; Hatase O; Hando T
    Gynecol Oncol; 1999 May; 73(2):202-9. PubMed ID: 10329035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p27(Kip1): regulation and function of a haploinsufficient tumor suppressor and its misregulation in cancer.
    Philipp-Staheli J; Payne SR; Kemp CJ
    Exp Cell Res; 2001 Mar; 264(1):148-68. PubMed ID: 11237531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas.
    Loda M; Cukor B; Tam SW; Lavin P; Fiorentino M; Draetta GF; Jessup JM; Pagano M
    Nat Med; 1997 Feb; 3(2):231-4. PubMed ID: 9018245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p27 Expression, a cyclin dependent kinase inhibitor in breast carcinoma.
    Barbareschi M
    Adv Clin Path; 1999 Oct; 3(4):119-27. PubMed ID: 10936889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent loss of expression of the cyclin-dependent kinase inhibitor p27 in epithelial ovarian cancer.
    Masciullo V; Sgambato A; Pacilio C; Pucci B; Ferrandina G; Palazzo J; Carbone A; Cittadini A; Mancuso S; Scambia G; Giordano A
    Cancer Res; 1999 Aug; 59(15):3790-4. PubMed ID: 10446997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers.
    Fredersdorf S; Burns J; Milne AM; Packham G; Fallis L; Gillett CE; Royds JA; Peston D; Hall PA; Hanby AM; Barnes DM; Shousha S; O'Hare MJ; Lu X
    Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6380-5. PubMed ID: 9177226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The p27/Kip1 locus shows no loss of heterozygosity in human pituitary adenomas.
    Wilson JC; Zhu JJ; Black PM
    J Neurooncol; 1999 Aug; 44(1):35-9. PubMed ID: 10582666
    [No Abstract]   [Full Text] [Related]  

  • 12. Regulation of the cdk inhibitor p27 and its deregulation in cancer.
    Slingerland J; Pagano M
    J Cell Physiol; 2000 Apr; 183(1):10-7. PubMed ID: 10699961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients.
    Porter PL; Malone KE; Heagerty PJ; Alexander GM; Gatti LA; Firpo EJ; Daling JR; Roberts JM
    Nat Med; 1997 Feb; 3(2):222-5. PubMed ID: 9018243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accommodating haploinsufficient tumor suppressor genes in Knudson's model.
    Cook WD; McCaw BJ
    Oncogene; 2000 Jul; 19(30):3434-8. PubMed ID: 10918600
    [No Abstract]   [Full Text] [Related]  

  • 15. Molecular markers of cancer progression. Ready or not, here they come.
    Taneja SS
    J Urol; 2000 Dec; 164(6):1996-7. PubMed ID: 11061899
    [No Abstract]   [Full Text] [Related]  

  • 16. Deregulated expression of p27(Kip1) in human breast cancers.
    Sgambato A; Zhang YJ; Arber N; Hibshoosh H; Doki Y; Ciaparrone M; Santella RM; Cittadini A; Weinstein IB
    Clin Cancer Res; 1997 Oct; 3(10):1879-87. PubMed ID: 9815577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism for inactivation of the KIP family cyclin-dependent kinase inhibitor genes in gastric cancer cells.
    Shin JY; Kim HS; Park J; Park JB; Lee JY
    Cancer Res; 2000 Jan; 60(2):262-5. PubMed ID: 10667572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of p27Kip1, cyclin E and c-myc expression with progression and prognosis in HPV-positive cervical neoplasms.
    Dellas A; Schultheiss E; Leivas MR; Moch H; Torhorst J
    Anticancer Res; 1998; 18(6A):3991-8. PubMed ID: 9891436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies.
    Kawamata N; Morosetti R; Miller CW; Park D; Spirin KS; Nakamaki T; Takeuchi S; Hatta Y; Simpson J; Wilcyznski S
    Cancer Res; 1995 Jun; 55(11):2266-9. PubMed ID: 7757974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of p27 expression in carcinoma of the oral cavity and oropharynx.
    Venkatesan TK; Kuropkat C; Caldarelli DD; Panje WR; Hutchinson JC; Chen S; Coon JS
    Laryngoscope; 1999 Aug; 109(8):1329-33. PubMed ID: 10443844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.